Mr. Kevin P. Starr is Chairman & Chief Executive Officer at Decibel Therapeutics, Inc., Chairman at SAGE Therapeutics, Inc., Chairman at Afferent Pharmaceuticals, Inc., Partner at Third Rock Ventures LLC and Independent Director at Alnylam Pharmaceuticals, Inc.
He is on the Board of Directors at MyoKardia, Inc., Global Blood Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Ember Therapeutics, Inc. and PanOptica, Inc.
Mr. Starr was previously employed as Chairman by Agios Pharmaceuticals, Inc., Independent Director by Zafgen, Inc., Chief Operating & Financial Officer by Millennium Pharmaceuticals, Inc., Controller by Biogen Idec MA, Inc., a Principal by Digital Equipment Corp., and Independent Director by Konarka Technologies, Inc.
He also served on the board at Human Genome Sciences, Inc. and Vitae Pharmaceuticals, Inc.
He received his undergraduate degree from Colby College and a graduate degree from Boston College.